-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
-
Summary
-
ELITE PHARMACEUTICALS INC /NV/ quarterly/annual Current Income Tax Expense (Benefit) history and change rate from 2022 to Q1 2025.
- ELITE PHARMACEUTICALS INC /NV/ Current Income Tax Expense (Benefit) for the quarter ending 31 Mar 2025 was $1.99M.
- ELITE PHARMACEUTICALS INC /NV/ Current Income Tax Expense (Benefit) for the twelve months ending 31 Mar 2025 was $468K, a 36.4% increase year-over-year.
- ELITE PHARMACEUTICALS INC /NV/ annual Current Income Tax Expense (Benefit) for 2024 was $468K, a 36.4% increase from 2023.
- ELITE PHARMACEUTICALS INC /NV/ annual Current Income Tax Expense (Benefit) for 2023 was $343K, a 19.1% decline from 2022.
Current Income Tax Expense (Benefit), Trailing 12 Months (USD)
Current Income Tax Expense (Benefit), Quarterly (USD)
Current Income Tax Expense (Benefit), YoY Quarterly Change (%)
Current Income Tax Expense (Benefit), Annual (USD)
Current Income Tax Expense (Benefit), YoY Annual Change (%)